Citadel Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19M Sell
71,339
-76,957
-52% -$20.8M ﹤0.01% 2393
2025
Q4
$37.2M Sell
148,296
-368,258
-71% -$97.8M 0.01% 1700
2025
Q3
$148M Buy
516,554
+376,298
+268% +$101M 0.02% 626
2025
Q2
$36.8M Buy
140,256
+137,948
+5,977% +$33.6M 0.01% 1495
2025
Q1
$537K Sell
2,308
-1,428,113
-100% -$347M ﹤0.01% 8313
2024
Q4
$328M Buy
1,430,421
+1,296,573
+969% +$297M 0.06% 242
2024
Q3
$29.9M Buy
+133,848
New +$29.4M 0.01% 1685
2024
Q2
Sell
-351,724
Closed -$71.5M 14934
2024
Q1
$76.8M Sell
351,724
-143,300
-29% -$31.6M 0.01% 892
2023
Q4
$113M Buy
495,024
+366,335
+285% +$77M 0.02% 617
2023
Q3
$25.9M Buy
128,689
+70,986
+123% +$15M 0.01% 1618
2023
Q2
$12M Sell
57,703
-379,316
-87% -$73.6M ﹤0.01% 2447
2023
Q1
$86.1M Buy
437,019
+283,175
+184% +$58.3M 0.02% 704
2022
Q4
$31.1M Sell
153,844
-52,087
-25% -$10.2M 0.01% 1523
2022
Q3
$36.2M Sell
205,931
-386,057
-65% -$79M 0.01% 1318
2022
Q2
$119M Buy
591,988
+230,020
+64% +$49M 0.03% 482
2022
Q1
$82M Sell
361,968
-288,654
-44% -$67.9M 0.02% 761
2021
Q4
$176M Sell
650,622
-80,928
-11% -$20M 0.04% 395
2021
Q3
$177M Buy
731,550
+122,801
+20% +$30.9M 0.04% 393
2021
Q2
$144M Sell
608,749
-162,194
-21% -$37M 0.03% 483
2021
Q1
$169M Buy
770,943
+517,401
+204% +$104M 0.04% 353
2020
Q4
$44.3M Sell
253,542
-398,858
-61% -$68.9M 0.01% 1047
2020
Q3
$106M Sell
652,400
-478,253
-42% -$75.8M 0.03% 435
2020
Q2
$161M Buy
1,130,653
+1,026,234
+983% +$142M 0.06% 234
2020
Q1
$11.3M Buy
104,419
+36,420
+54% +$5.25M 0.01% 1728
2019
Q4
$9.88M Sell
67,999
-542,015
-89% -$78.3M ﹤0.01% 2209
2019
Q3
$88M Sell
610,014
-394,579
-39% -$57.6M 0.04% 457
2019
Q2
$149M Buy
1,004,593
+132,713
+15% +$18.5M 0.07% 247
2019
Q1
$115M Buy
871,880
+432,577
+98% +$53.3M 0.06% 313
2018
Q4
$47.7M Buy
439,303
+210,948
+92% +$28.3M 0.03% 651
2018
Q3
$34.1M Buy
228,355
+224,489
+5,807% +$34.1M 0.02% 993
2018
Q2
$596K Sell
3,866
-134,474
-97% -$20.3M ﹤0.01% 6083
2018
Q1
$19.2M Sell
138,340
-23,224
-14% -$3.41M 0.01% 1149
2017
Q4
$22.1M Sell
161,564
-322,346
-67% -$42.6M 0.01% 1101
2017
Q3
$62.8M Sell
483,910
-18,252
-4% -$2.43M 0.05% 429
2017
Q2
$66.5M Buy
502,162
+228,132
+83% +$27.9M 0.06% 374
2017
Q1
$33.8M Buy
274,030
+254,702
+1,318% +$30.2M 0.03% 643
2016
Q4
$2.13M Buy
+19,328
New +$2.15M ﹤0.01% 2877
2016
Q3
Sell
-67,990
Closed -$8.01M 7510
2016
Q2
$7.61M Buy
67,990
+26,290
+63% +$2.83M 0.01% 1463
2016
Q1
$4.2M Buy
41,700
+33,565
+413% +$3.22M 0.01% 1923
2015
Q4
$864K Sell
8,135
-217,609
-96% -$22.4M ﹤0.01% 3755
2015
Q3
$21M Buy
225,744
+141,991
+170% +$14.7M 0.02% 871
2015
Q2
$8.72M Buy
83,753
+31,392
+60% +$3.27M 0.01% 1567
2015
Q1
$5.67M Buy
52,361
+21,921
+72% +$2.25M 0.01% 1902
2014
Q4
$2.82M Sell
30,440
-809,435
-96% -$71.5M ﹤0.01% 2546
2014
Q3
$73.4M Buy
839,875
+540,817
+181% +$48.9M 0.08% 263
2014
Q2
$26.3M Buy
299,058
+229,185
+328% +$19.9M 0.03% 667
2014
Q1
$5.9M Buy
69,873
+8,300
+13% +$662K 0.01% 1630
2013
Q4
$4.83M Sell
61,573
-102,568
-62% -$8.75M 0.01% 1720
2013
Q3
$14M Sell
164,141
-49,394
-23% -$4.16M 0.02% 908
2013
Q2
$18.4M Buy
+213,535
New +$17.7M 0.03% 701

Other funds holding LH

Citadel Advisors's LH Position: Q1 2026 in Review

Citadel Advisors reduced its Labcorp (LH) stake by 52% in Q1 2026, selling an estimated $20.8M and leaving 71,339 shares worth $19M. The position accounts for ﹤0.01% of the portfolio, ranked #2393.

Citadel Advisors first reported a position in LH in Q2 2013 and has held it in 50 quarters since. The position peaked at $328M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Citadel Advisors held 71,339 shares of Labcorp worth $19M as of Q1 2026.
  • Citadel Advisors sold 76,957 Labcorp shares in Q1 2026, an estimated $20.8M.
  • Labcorp made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2393 holding.
  • Citadel Advisors first reported a position in Labcorp in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Labcorp position peaked at $328M in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.